TRIMT is a science- and data-driven company founded by scientists, managed and operated by experts with a strong scientific background and supported by an interdisciplinary advisory board.
For pharmaceutical and clinical developments that address unmet clinical needs, TRIMT relies on an integrated network of academic and clinical collaborations and on the best available industrial partner options.
For the benefit of patients, TRIMT seeks to unlock the full potential of its unique intellectual property portfolio through a strategic, diversified selection of short- and long-term development objectives. TRIMT values a creative, unconventional approach to thinking and communication that leads to disruptive innovation.
As Nukleon, we serve as the authorized distributor of TRIMT’s Trivehexin ve Therahexin products in the Turkish market.
For more information, you can visit trimt.de ↗.